Alto Ingredients earnings beat by $0.05, revenue topped estimates

Alto Ingredients (ALTO) reported Q3 EPS of $0.16, beating estimates by $0.05, with revenue of $257.9M, exceeding expectations. The stock is down 20.27% over 3 months but up 201.72% over 12 months. InvestingPro rates its financial health as 'great performance'.

Original reporting
Published Nov 4, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALTO
Bullish
high confidence
Mentioned
$ALTO
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ALTOBullishMed
01

Why it matters

The earnings surprise could attract short‑term buying interest, but the small market cap may limit broader impact.

02

Market read

Earnings beat provides a modest trading catalyst for ALTO.

03

What to watch

Potential margin pressure from higher input costs not discussed.

Relevance 6/10Novelty 7/10Timing: after-hours reaction

Background

Alto Ingredients is a specialty ingredients producer listed on NASDAQ. The company posted a strong Q3 earnings beat.

Company-level read

Ticker impact

$ALTOBullishHigh confidence
Context

Alto Ingredients reported Q3 EPS of $0.160, beating estimates by $0.05 and revenue of $257.9M, topping the $248.5M consensus.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The beat exceeds expectations on both EPS and revenue, which typically drives a positive price reaction for a small‑cap stock.

Market effects

Positive earnings may lift sentiment in the specialty ingredients sector.

US market, small‑cap segment.

Limited to investors tracking micro‑cap earnings.

Counterpoint

The beat may already be priced in, limiting upside.

Key entities

  • Alto Ingredients

    NASDAQ‑listed specialty ingredients producer.

Related articles

$ALTOMed

Alto Ingredients, Inc. Reports Third Quarter 2026 Results

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Ingredients, Inc. Reports Third Quarter 2026 Results Q3 2026 Net Income of $12.7 Million, or $0.16 per Share Q3 2026 Adjusted EBITDA of $21.0 Million Pekin, Ill., November 4, 2026 – Alto Ingredients, Inc. (NASDAQ: ALTO) , a leading producer and distributor of re

$ALTOMedAI 9/10

Alto (ALTO) Q2 2026 Earnings Call Transcript

Alto Ingredients (ALTO) reported Q2 2026 results in an earnings call. Net sales rose to $245.7M, adjusted EBITDA was $23.7M, and net income attributable to common stockholders was $11.4M ($0.15/diluted share). Full-year Section 45Z guidance is $15M to $16M. Management discussed capacity expansion, CO2 storage, and a $50M at-the-market equity program.

$ALTOMed

Alto Ingredients, Inc. Reports Second Quarter 2026 Results

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Ingredients, Inc. Reports Second Quarter 2026 Results Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million Pe

$AAONHighAI 8/10

AAON Stock Jumps 23% After Q3 Beat and Higher 2026 Sales Outlook

AAON stock surged 23% to $77 after Q3 earnings beat estimates, with adjusted EPS of $0.83 vs. $0.57 expected and record revenue of $707.4M. BASX data center cooling sales rose 218% to $397.2M. AAON raised its 2026 sales outlook to $2.48B-$2.524B and declared a $0.10 dividend. The company restated early 2026 results and disclosed a material weakness in financial reporting controls.